Daiken Medical Co., Ltd. (TYO:7775)

Daiken Medical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	2,311	2,995	2,739	2,516	2,518	2,170
Cash & Short-Term Investments	2,311	2,995	2,739	2,516	2,518	2,170
Cash Growth	-26.77%	9.35%	8.86%	-0.08%	16.04%	-8.24%
Receivables	2,559	2,471	2,479	2,530	2,431	2,587
Inventory	1,556	1,430	1,438	1,514	1,544	1,421
Prepaid Expenses	-	42	24	18	19	23
Other Current Assets	112	47	50	60	60	71
Total Current Assets	6,538	6,985	6,730	6,638	6,572	6,272
Property, Plant & Equipment	4,018	3,931	3,986	4,070	4,119	4,225
Long-Term Investments	71	68	70	65	53	67
Other Intangible Assets	11	12	13	9	15	21
Long-Term Deferred Tax Assets	188	183	205	230	160	166
Other Long-Term Assets	2	2	2	1	1	1
Total Assets	10,828	11,181	11,006	11,013	10,920	10,752
Accounts Payable	1,044	1,027	1,066	1,117	1,004	957
Accrued Expenses	72	69	65	70	70	179
Short-Term Debt	620	746	1,114	1,058	1,019	1,033
Current Portion of Long-Term Debt	420	480	389	659	597	704
Current Portion of Leases	-	4	8	9	11	11
Current Income Taxes Payable	189	484	671	428	427	259
Other Current Liabilities	197	19	26	28	23	204
Total Current Liabilities	2,542	2,829	3,339	3,369	3,151	3,347
Long-Term Debt	633	818	623	1,013	1,280	1,177
Long-Term Leases	-	3	8	16	26	28
Other Long-Term Liabilities	28	16	14	19	18	18
Total Liabilities	3,203	3,666	3,984	4,417	4,475	4,570
Common Stock	495	495	495	495	495	495
Additional Paid-In Capital	400	400	400	400	400	400
Retained Earnings	8,524	8,414	7,920	7,506	7,368	7,112
Treasury Stock	-1,826	-1,826	-1,826	-1,826	-1,826	-1,826
Comprehensive Income & Other	32	32	33	21	8	1
Shareholders' Equity	7,625	7,515	7,022	6,596	6,445	6,182
Total Liabilities & Equity	10,828	11,181	11,006	11,013	10,920	10,752
Total Debt	1,673	2,051	2,142	2,755	2,933	2,953
Net Cash (Debt)	638	944	597	-239	-415	-783
Net Cash Growth	-8.07%	58.12%	-	-	-	-
Net Cash Per Share	22.21	32.86	20.78	-8.32	-14.45	-27.26
Filing Date Shares Outstanding	28.73	28.73	28.73	28.73	28.73	28.73
Total Common Shares Outstanding	28.73	28.73	28.73	28.73	28.73	28.73
Working Capital	3,996	4,156	3,391	3,269	3,421	2,925
Book Value Per Share	265.42	261.59	244.43	229.60	224.34	215.19
Tangible Book Value	7,614	7,503	7,009	6,587	6,430	6,161
Tangible Book Value Per Share	265.03	261.17	243.97	229.29	223.82	214.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.